AIDP, Inc.   Report issue

For profit Phase 2
Founded: City of Industry CA United States (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2018
NCT03462199
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

AIDP, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

kiwi fruit (1 trial)

xylooligosaccharide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2